{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:32Z","timestamp":1790839952480,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB\/TR3 TP A7"],"award-info":[{"award-number":["SFB\/TR3 TP A7"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.clineuro.2010.09.016","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T15:30:17Z","timestamp":1302881417000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["24-Months results in two adults with Pompe disease on enzyme replacement therapy"],"prefix":"10.1016","volume":"113","author":[{"given":"Stefan","family":"Vielhaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brejova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Debska-Vielhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Feistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea A.","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Awiszus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2010.09.016_bib0005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mus.1103","article-title":"Muscle glycogenoses","volume":"24","author":"DiMauro","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease, a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0020","series-title":"Myology","article-title":"Metabolic disorders affecting muscle. Acid maltase deficiency","author":"Engel","year":"1994"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0025","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","article-title":"Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease","volume":"19","author":"Van der Beek","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late-onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"M\u00fcller-Felber","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0040","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mus.880181414","article-title":"Glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Reuser","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"Van Capelle","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mus.1053","article-title":"Physiological alterations of maximal voluntary quadriceps activation by changes of knee joint angle","volume":"24","author":"Becker","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2006.02.161","article-title":"Strength and voluntary activation of quadriceps femoris muscle in total knee arthroplasty with midvastus and subvastus approaches","volume":"22","author":"Berth","year":"2007","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073807302598","article-title":"Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from Chinese hamster ovary cells","volume":"22","author":"Rossi","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mus.880040304","article-title":"Clinical trial in Duchenne dystrophy. I. The design of the protocol","volume":"4","author":"Brooke","year":"1981","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0105","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"ATS statement: lung function testing: selection of reference values and interpretative strategies","volume":"144","author":"American Thoracic Society (ATS)","year":"1991","journal-title":"Am Rev Respir Disease"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0277-9536(95)00115-N","article-title":"German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment","volume":"41","author":"Bullinger","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0115","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.WNL.0000142597.69707.78","article-title":"Late-onset Pompe disease primarily affects quality of life in physical health domains","volume":"63","author":"Hagemans","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0125","series-title":"The SF-36 health survey. Quality of life and pharmacoeconomics in clinical trials","author":"Ware","year":"1996"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.orthres.2003.11.004","article-title":"Neuromuscular quadriceps dysfunction prior to osteoarthritis of the knee","volume":"22","author":"Becker","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2008.09.001","article-title":"Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: a case study","volume":"95","author":"Case","year":"2008","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.clineuro.2010.09.016_bib0140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","article-title":"Glycogen storage disease type II (Pompe disease)\u2014influence of enzyme replacement therapy in adults","volume":"16","author":"Merk","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nmd.2003.08.003","article-title":"Muscle MRI in adult-onset acid maltase deficiency","volume":"14","author":"Pichiecchio","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation","volume":"55","author":"Lafor\u00eat","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0155","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1183\/09031936.05.00112005","article-title":"Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives","volume":"26","author":"van der Ploeg","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0165","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2002.09.097","article-title":"Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma","volume":"20","author":"Dudeney","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0170","first-page":"463","article-title":"The SF-36 general health status survey documents the burden of osteoarthritis and the benefits of total joint arthroplasty: but why should we use it?","volume":"8","author":"Kiebzak","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1302\/0301-620X.80B2.0800360","article-title":"Health status after Ilizarov reconstruction of post-traumatic lower-limb deformity","volume":"80","author":"McKee","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.clineuro.2010.09.016_bib0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410380316","article-title":"Genotype\u2013phenotype correlation in adult-onset acid maltase deficiency","volume":"38","author":"Wokke","year":"1995","journal-title":"Ann Neurol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710003082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710003082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:27:59Z","timestamp":1759588079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846710003082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0303846710003082"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.09.016","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"24-Months results in two adults with Pompe disease on enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}